Cumberland Pharmaceuticals
Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Information

Contact top employees from Cumberland Pharmaceuticals

Summary

Cumberland Pharmaceuticals is a public company that has been in the industry for 26 years. The company currently specializes in the Pharmaceuticals area. The position of the Chairman & CEO is occupied by A. J. Kazimi. Its headquarters is located at Nashville, Tennessee, USA. The number of employees ranges from 25 to 100. The annual revenue of Cumberland Pharmaceuticals varies between 25M and 100M. Total funding of the company - $87.2M. To connect with Cumberland Pharmaceuticals employee register on SignalHire.

Industries

Pharmaceuticals

Employees Size

100-200 employees

SIC Code

2834

DMA Code

Nashville Metropolitan Area

Founded

1999

Estimated Annual Revenue

$25M - 100M

Operating Status

Independent Company

Contact Cumberland Pharmaceuticals

Organization Website

Social Links

facebooklinkedIn

Contact Email

info@cumberlandpharma.com

Phone Number

615-255-0068

Competitors

Founded
Type
Employees
Revenue
Funding
1998Public
Company
100 - 250 413M $652.8M
1996Public
Company
100 - 250 103.6M $193M
2000Public
Company
250 - 500 96.4M $558.3M
1931Public
Company
50K - 100K 12.2B $1.8M

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Current employees switched from
Ex-employees switched to
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Cumberland Pharmaceuticals shows a diverse range of experience levels:
3% have been with the company for less than 1 year5% for 1–2 years10% for 3–4 years8% for 5–7 years7% for 8–10 years67% have over 11 years of service at Cumberland Pharmaceuticals
Ex-employees positions
In Company
In New Company
Contact top employees from Cumberland Pharmaceuticals
Gregg Johnston
Director of National Accounts
View
David Cobb
Hospital Account Manager
View
Andy Anderson
Specialty Hospital Account Manager
View
Veronica Jordan
Hospital Account Manager
View
Jane Gosser
Hospital Account Manager
View
Ingrid Anderson
Senior Clinical Project Manager
View
Christine Lofton Wooddall
Hospital Account Manager
View
Regina Cerna
Hospital Account Manager
View
Jose Montes
Hospital Account Manager
View
Breanne Gibson
Senior Clinical Scientist
View
Machaela Byram
National Account Manager
View
Allison Womble
Hospital Account Manager
View
Nellie
Marketing Director
View
Joe Galante
Member Board Of Directors
View
Mick Payne
Hospital Sales/Oncology/Pain Management
View
Scottie Stanley
Hospital Sales
View
Jim Rynne
Hospital sales representative
View
Beth Zaborny
Director of Regulatory Affairs
View
Ernest Spann
Pharmaceuticals Sales
View
Suzette Berkhan
Hospital Regional Business Manager - South
View
Marinda Flowers
Field/Hospital Sales
View
Jim Clement
District Sales Manager - Hospital
View
Jami McCool
Field Sales Representative
View
Flint Palmer
Field Sales Representative
View
Denise Brys
Strategic Account Manager/ Divisional Trainer
View
Daniel Garcia
Medical Science Liaison
View
Robin Seyburn RN
Executive Hospital Sales Representative
View
Mike Tasos
Executive District Manager
View
John Osting
Hospital Sales Representative
View
Joe Mullin
Senior Hospital Account Manager
View

FAQ

Cumberland Pharmaceuticals operates in the Pharmaceuticals industries. More details can be found on the official website: cumberlandpharma.com.
The headquarters of Cumberland Pharmaceuticals are located in , .
The current CEO of Cumberland Pharmaceuticals is A. J. Kazimi
You can contact Cumberland Pharmaceuticals by phone at 615-255-0068.
Cumberland Pharmaceuticals currently employs 100-200 people.
You can contact Cumberland Pharmaceuticals by phone at 615-255-0068, by email at info@cumberlandpharma.com, through social media (Facebook, LinkedIn), or via the contact form on cumberlandpharma.com.
Cumberland Pharmaceuticals's revenue is approximately 39.1M.
Well-known competitors of Cumberland Pharmaceuticals include Ironwood Pharmaceuticals, Paratek Pharmaceuticals, Melinta Therapeutics and Baxter International Inc..
BACK TO TOP